Abstract
To produce human monoclonal antibodies in bacteria, a gene repertoire of IgM variable regions was isolated from human peripheral B lymphocytes by the polymerase chain reaction. Alternatively, synthetic antibody genes with random hypervariable regions are being generated that may provide libraries of even higher complexity. For the selection of specific monoclonal antibodies from these libraries, we have developed twoE. coli vector systems that facilitate the surface display of an antibody physically linked to its own gene. The phagemid pSEX encodes a fusion protein of an antigen binding domain (Fv-antibody) with the docking protein (pIII) of filamentous phages. Specific antibody genes can therefore be enriched by antigen affinity chromatography. The plasmid pAP1 encodes a fusion protein of an Fv-antibody with a bacterial cell-wall protein. Bacteria carrying this plasmid express functional Fv-antibodies tightly bound to their surface. This should enable the selection of single cells with a fluorescence-assisted cell sorter (FACS) using labeled antigen or by adsorption to immobilized antigen.
These vectors permit three major principles of the antibody response to be mimicked inE. coli:
-
1.
Generation of a highly complex antibody repertoire;
-
2.
Clonal selection procedures for library screening; and
-
3.
The possibility of increasing a given affinity by repeated rounds of mutation and selection.
Similar content being viewed by others
References
Courtenay-Luck, N. S., Epenetos, A. A., Moore, R., Larche, M., Pectasides, D., Dhokia, B., and Ritter, M. A. (1986) Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms.Cancer Res. 46, 6489–6493.
Winter, G. and Milstein, C. (1991) Man made antibodies.Nature 349, 293–299.
Skerra, A. and Plückthun, A. (1988) Assembly of a functional immunoglobulin Fv fragment inEscherichia coli.Science 240, 1038–1041.
Better, M., Chang, C. P., Robinson, R. R., and Horowitz, A. H. (1988)Escherichia coli secretion of an active chimeric antibody fragment.Science 240, 1041–1043.
Huston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M. S., Novotny, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., Crea, R., and Oppermann, H. (1988) Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced inEscherichia coli.Proc. Natl. Acad. Sci. USA 85, 5879–5883.
Dübel, S., Breitling, F., Seehaus, T., and Little, M. (1992) Generation of a human IgM expression library inE. coli.Meth. Mol. Cell Biol. 3, 47–52.
Kilmartin, J. V., Wright, B., and Milstein, C. (1982) Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line.J. Cell Biol. 93, 576–582.
Breitling, F. and Little, M. (1986) Carboxy-terminal regions on the surface of tubulin and microtubules. Epitope locations of YOL1/34, DM1A, and DM1B.J. Mol. Biol. 189, 367–370.
Little, M., Breitling, F., Seehaus, T., Dübel, S., and Klewinghaus, I. (1991) Facile production of human monoclonal antibodies.Curr. Opin. Therap. Pat. 1, 1515,1516.
Seehaus, T., Breitling, F., Dübel, S., Klewinghaus, I., and Little, M. (1992) A vector for the removal of deletion mutants from antibody libraries.Gene 114, 235–237.
Breitling, F., Dübel, S., Seehaus, T., Klewinghaus, I., and Little, M. (1991) A surface expression vector for antibody screening.Gene 104, 147–153.
Dübel, S., Breitling, F., Klewinghaus, I., and Little, M. (1992) Regulated secretion and purification of recombinant antibodies inE. coli.Cell Biophys. 21, 69–79.
Fuchs, P., Breitling, F., Dübel, S., Seehaus, T., and Little, M. (1991) Targeting recombinant antibodies to the surface ofE. coli: fusion to a peptidoglycan associated lipoprotein.Bio/Technology 9, 1369–1372.
Kang, A. S. T., Jones, T. M., and Burton, D. R. (1991) Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries.Proc. Natl. Acad. Sci. USA 88, 11,120–11,123.
Barbas, III, C. F., Bain, J. D., Hoekstra, D. M., and Lerner, R. A. (1992) Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem.Proc. Natl. Acad. Sci. USA 89, 4457–4461.
Sulkowski, E. (1985) Purification of proteins by IMAC.Trends in Biotechnology 3, 1–7.
Lilius, G., Person, M., Bülow, L., and Mosbach, K. (1991) Metal affinity recipitation of proteins carrying genetically attached polyhistidine tails.Eur. J. Biochem. 198, 499–504.
Evan, G. I., Lewis, G. K., Ramsay, G., and Bishop, M. (1985) Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.Mol. Cell. Biol. 5, 3610–3616.
Neuberger, M. S. (1983) Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.EMBO J. 2, 1372–1378.
Nitta, T., Sato, K., Yagita, H., Okumura, K., and Ishii, S. (1990) Preliminary trial of specific targeting therapy against malignant glioma.Lancet 335, 368–371.
Chaudhary, V. K., Queen, C., Junghans, R. P., Waldmann, T. A., FitzGerald, D. J., and Pastan, I. (1989) A recombinant immunotoxin consisting of two antibody variable domains fused toPseudomonas exotoxin.Nature 339, 394–397.
Rybak, S. M., Hoogenboom, H. R., Meade, H. M., Raus, J. C. M., Schwartz, D., and Youle, R. J. (1992) Humanization of immunotoxins.Proc. Natl. Acad. Sci. USA 89, 3165–3169.
Bagshawe, K. D., Springer, C. J., Searle, F., Antoniw, P., Sharma, S. K., Melton, R. G., and Sherwood, R. F. (1988) A cytotoxic agent can be generated selectively at cancer sites.Br. J. Cancer 58, 700–703.
Meyer D. L., Jungheim, L. N., Mikolajczyk, S. D., Shepherd, T. A., Starling, J. J., and Ahlem, C. N. (1992) Preparation and characterization of a beta-lactamase-Fab' conjugate for the site-specific activation of oncolytic agents.Bioconjug. Chem. 3, 42–48.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fuchs, P., Dübel, S., Breitling, F. et al. Recombinant human monoclonal antibodies. Cell Biophysics 21, 81–91 (1992). https://doi.org/10.1007/BF02789480
Issue Date:
DOI: https://doi.org/10.1007/BF02789480